MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer

BACKGROUND: Recent evidence indicated that the aberrant expression of microRNA plays a crucial role in the development of cervical cancer. The overall shorter survival was strongly related to the abnormal expression of microRNA-34a (miR-34a) and microRNA-206 (miR-206), which target B cell lymphoma-2...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Cell Int
Hlavní autoři: Chen, Ai-Hua, Qin, Yu-E, Tang, Wen-Fan, Tao, Jing, Song, Hua-mei, Zuo, Manzhen
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Primary Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5466768/
https://ncbi.nlm.nih.gov/pubmed/28615991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-017-0431-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky